ImmunoPrecise Antibodies Says Preclinical Data From Co’s Drug Pipeline To Be Presented During BIO International Partnering Event From June 14-18
IMMUNOPRECISE ANTIBODIES LTD (the "Company" or "IPA") (NASDAQ:IPA) (TSXV:IPA) today announced the results from in vitro characterizations investigating TATX-21, a novel potential